Biotech Companies

743 companies | Drug discovery and development companies

#	COMPANY	THERAPEUTIC AREAS	STAGE
1.	180 Collagen (NZ) Limited Te Awamutu, New Zealand		Commercial	VIEW
2.	4 Animals AlsterScience GmbH Hamburg, Germany	Immunology Oncology Infectious Disease	Preclinical	VIEW
3.	4D Pharma plc Leeds, United Kingdom	Oncology Immunology Gastroenterology	Preclinical to Phase II (at time of administration)	VIEW
4.	AC Immune SA Lausanne, Switzerland		Phase 2	VIEW
5.	ACI Limited Dhaka, Bangladesh		Commercial	VIEW
6.	ADARx Pharmaceuticals San Diego, USA	Neuroscience Immunology Oncology	Phase 3	VIEW
7.	ADMA Biologics, Inc. Ramsey, New Jersey, United States		Commercial + Preclinical	VIEW
8.	AGS Therapeutics Paris, France	Ophthalmology Immunology Infectious Disease+2	Preclinical	VIEW
9.	ARCS Australia North Sydney, Australia		-	VIEW
10.	ASKA Pharmaceutical Co., Ltd. Tokyo, Japan	Gastroenterology	Commercial	VIEW
11.	Aardvark Therapeutics San Diego, USA	Rare Diseases Metabolic	Phase 3	VIEW
12.	AbCellera Vancouver, Canada	Metabolic Immunology Oncology	Phase 2	VIEW
13.	Abbisko Therapeutics Shanghai, China	Oncology	Phase 3	VIEW
14.	Abcuro, Inc. Newton, Massachusetts, USA	Immunology Oncology Rare Diseases	Phase 2/3	VIEW
15.	Abdera Therapeutics South San Francisco, USA / Vancouver, Canada	Oncology	Phase 1	VIEW
16.	Abeona Therapeutics Inc. Cleveland, Ohio, USA	Rare Diseases Ophthalmology Dermatology	Commercial	VIEW
17.	Abiogen Pharma S.p.A. Pisa, Italy	Respiratory Metabolic Dermatology+1	Commercial	VIEW
18.	Abivax Paris, France	Immunology Gastroenterology	Phase 3	VIEW
19.	Acadia Pharmaceuticals Inc. San Diego, USA	Neuroscience Rare Diseases	Commercial	VIEW
20.	Acelot South San Francisco, California, USA	Metabolic Oncology	Preclinical	VIEW
21.	Acrux Melbourne, Australia	Dermatology Metabolic	Commercial	VIEW
22.	Actinogen Medical Sydney, Australia		Phase 2/3	VIEW
23.	Advanz Pharma London, United Kingdom	Gastroenterology Metabolic Oncology+2	Commercial\|Phase 2\|Phase 3	VIEW
24.	Aerogen Pharma San Mateo, USA / Galway, Ireland	Respiratory	Phase 3	VIEW
25.	Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA)	Oncology Immunology Infectious Disease	Clinical	VIEW
26.	Agios Pharmaceuticals Cambridge, USA	Rare Diseases Hematology Metabolic	Commercial	VIEW
27.	Agomab Therapeutics Antwerp, Belgium	Gastroenterology Rare Diseases	Phase 2	VIEW
28.	Ajou University Suwon, South Korea	Oncology Immunology Neuroscience+2	Phase 3	VIEW
29.	Akebia Therapeutics Cambridge, USA	Rare Diseases	Commercial	VIEW
30.	Akribes Biomedical Vienna, Austria	Dermatology	Preclinical	VIEW
31.	Al-Razi Pharma Industries Dammam, Saudi Arabia		Commercial	VIEW
32.	Alembic Pharmaceuticals Limited Vadodara, India	Cardiovascular Dermatology Oncology+3	Commercial	VIEW
33.	Alkermes plc Dublin, Ireland	Neuroscience	Commercial	VIEW
34.	Alkeus Pharmaceuticals Cambridge, USA	Ophthalmology Rare Diseases	Phase 3	VIEW
35.	Allergy Therapeutics Worthing, United Kingdom		Phase 3 and Phase 1/2	VIEW
36.	Allygen Biosciences Shanghai, China	Oncology Immunology	Preclinical	VIEW
37.	Alnylam Pharmaceuticals Cambridge, USA	Infectious Disease	Commercial	VIEW
38.	AltruBio, Inc. San Francisco, USA	Immunology	Phase 2	VIEW
39.	Alumis Inc. South San Francisco, USA	Immunology Dermatology Neuroscience+1	Phase 3	VIEW
40.	Amarin Corporation plc Dublin, Ireland	Cardiovascular	Commercial	VIEW
41.	Ampersand Biomedicines Boston, MA, USA	Metabolic	Preclinical	VIEW
42.	Amylyx Pharmaceuticals Cambridge, USA	Rare Diseases	Phase 3	VIEW
43.	Anavex Life Sciences Corp. New York, United States	Oncology	Phase 2\|Phase 3	VIEW
44.	Angelini Pharma Rome, Italy	Neuroscience Infectious Disease	Phase 3	VIEW
45.	Anocca AB Södertälje, Sweden	Oncology Immunology Infectious Disease	Phase 1	VIEW
46.	Antaria Limited Perth, Australia		-	VIEW
47.	Anyea Therapeutics Co., Ltd. Shanghai, China	Neuroscience	Discovery	VIEW
48.	Apellis Pharmaceuticals, Inc. Waltham, Massachusetts, USA	Ophthalmology Rare Diseases Immunology	Commercial	VIEW
49.	ApicHope Pharmaceutical Group Co., Ltd. Guangzhou, China	Metabolic Infectious Disease	Phase 3	VIEW
50.	Apogee Therapeutics, Inc. Waltham, USA	Dermatology Respiratory	Phase 2	VIEW
51.	Apotex Inc. Toronto, Canada	Cardiovascular Oncology Neuroscience+1	Commercial	VIEW
52.	Aprogen Seongnam-si, South Korea	Oncology Immunology	Commercial	VIEW
53.	Apsen Farmacêutica São Paulo, Brazil	Neuroscience Gastroenterology	Phase 3	VIEW
54.	Aquinas Companies, LLC (Fannin Innovation Studio) Houston, Texas, USA	Oncology Infectious Disease Cardiovascular+2	Phase 2	VIEW
55.	Araceli Biosciences Tigard, Oregon, United States		Seed	VIEW
56.	Aramis Biotechnologies Quebec City, Canada	Infectious Disease	Phase 1/2	VIEW
57.	Arcera Life Sciences Abu Dhabi, United Arab Emirates	Neuroscience Cardiovascular Gastroenterology+1	Commercial	VIEW
58.	Arcus Biosciences Hayward, United States	Oncology Immunology	Phase 3	VIEW
59.	Arcutis Biotherapeutics Westlake Village, California, United States	Dermatology	Commercial & Phase 1/2	VIEW
60.	Ardelyx Waltham, Massachusetts, USA	Gastroenterology	Commercial	VIEW
61.	Argo Biopharma Shanghai, China	Cardiovascular Metabolic Hematology+2	Phase 2	VIEW
62.	Aristo Pharmaceuticals Private Limited Mumbai, India	Gastroenterology Respiratory	Commercial	VIEW
63.	Aristopharma Ltd. Dhaka, Bangladesh	Oncology Cardiovascular	Commercial	VIEW
64.	Ark Biosciences Shanghai, China	Respiratory Infectious Disease Neuroscience	Commercial	VIEW
65.	Arrivo BioVentures Morrisville, USA	Neuroscience Gastroenterology	Phase 2	VIEW
66.	Arrowhead Pharmaceuticals Pasadena, California, United States	Metabolic	Commercial \| Phase 3 \| Phase 2 \| Phase 1	VIEW
67.	Artica Therapeutics Leiden, Netherlands	Immunology	Preclinical	VIEW
68.	Artificial Axon Labs Cambridge, Massachusetts, USA	Neuroscience	Discovery	VIEW
69.	Arvinas, Inc. New Haven, Connecticut, United States	Oncology Neuroscience	Phase 1-3	VIEW
70.	Ascentage Pharma Suzhou, China	Oncology	Commercial	VIEW
71.	Asimetra Biotech Solutions Girona, Spain		-	VIEW
72.	AskGene Camarillo, California, United States	Oncology Immunology Ophthalmology	Phase 3	VIEW
73.	Asklepion Pharmaceuticals, LLC Baltimore, Maryland, USA		Phase 3	VIEW
74.	Asklepios BioPharmaceutical Research Triangle Park, North Carolina, USA	Metabolic	Phase 1\|Phase 2\|Preclinical	VIEW
75.	Aspen Global Incorporated Grand Bay, Mauritius	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
76.	Assertio Holdings, Inc. Lake Forest, USA	Neuroscience Immunology Oncology	Commercial	VIEW
77.	Assistance Publique - Hôpitaux de Marseille (AP-HM) Marseille, France	Rare Diseases Oncology	Clinical	VIEW
78.	AtaiBeckley (formerly ATAI Life Sciences) Berlin, Germany (original); U.S. redomiciliation completed December 30, 2025		Phase 2	VIEW
79.	Atara Biotherapeutics, Inc. Thousand Oaks, California, USA	Oncology Immunology	Clinical	VIEW
80.	Atea Pharmaceuticals Boston, Massachusetts, United States		Phase 3 (HCV), Phase 1 planned (HEV)	VIEW
81.	Aucta Pharmaceuticals Basking Ridge, New Jersey, USA	Dermatology Ophthalmology Respiratory	Commercial \| Phase 2 \| Preclinical	VIEW
82.	Autobahn Therapeutics San Diego, USA	Neuroscience	Phase 2	VIEW
83.	Autolus Therapeutics London, United Kingdom	Oncology Immunology Rare Diseases	Commercial + Phase 1/2	VIEW
84.	Avalon Pharma (Middle East Pharmaceutical Industries Co.) Riyadh, Saudi Arabia	Dermatology Respiratory Cardiovascular+3	Commercial	VIEW
85.	Avenzo Therapeutics San Diego, USA	Oncology	Phase 2	VIEW
86.	Axalbion Lausanne, Switzerland	Respiratory Ophthalmology Neuroscience	Phase 2	VIEW
87.	AziraMed Strategy Waterford, Ireland		-	VIEW
88.	Azurity Pharmaceuticals Woburn, USA	Cardiovascular Metabolic Gastroenterology+2	Commercial	VIEW
89.	B.Grimm Pharma Bangkok, Thailand	Cardiovascular Gastroenterology Infectious Disease+1	Commercial	VIEW
90.	BGI Group Shenzhen, China	Oncology Rare Diseases Infectious Disease	Commercial	VIEW
91.	BIAL São Mamede do Coronado, Trofa, Porto, Portugal	Cardiovascular Rare Diseases	Phase 2 (lead candidate)	VIEW
92.	BIKEN Foundation Suita, Japan	Infectious Disease	Commercial	VIEW
93.	BIOCAD Saint Petersburg, Russia	Oncology Immunology Infectious Disease	Commercial	VIEW
94.	BIOVIIIx Naples, Italy	Rare Diseases Hematology Oncology	Discovery	VIEW
95.	BRIM Biotechnology, Inc. Taipei, Taiwan	Ophthalmology Rare Diseases	Phase 3	VIEW
96.	Basilea Pharmaceutica Allschwil, Switzerland	Infectious Disease	Phase 3	VIEW
97.	BeBioSol India		-	VIEW
98.	BeOne Medicines (formerly BeiGene) Cambridge, Massachusetts, United States (corporate); Basel, Switzerland (post-redomiciliation May 2025)	Oncology	Phase 1-3 and Commercial	VIEW
99.	Beijing Sungen Biomedical Technology Co., Ltd. Beijing, China	Cardiovascular Oncology Infectious Disease	Phase 2	VIEW
100.	Belenos Biosciences New York, NY, USA	Immunology Respiratory Dermatology	Phase 1/2	VIEW
101.	Belief BioMed Shanghai, China	Rare Diseases Hematology Neuroscience+1	Commercial	VIEW
102.	BenevolentAI London, United Kingdom	Oncology Immunology Neuroscience+3	Phase 1\|Phase 2\|Preclinical	VIEW
103.	Benitec Biopharma Inc. Hayward, California, USA	Infectious Disease Oncology	Phase 1b/2a (BB-301), Preclinical (other programs)	VIEW
104.	Beren Therapeutics P.B.C. Thousand Oaks, USA	Rare Diseases	Phase 3	VIEW
105.	Berg Health Framingham, Massachusetts, USA	Oncology Neuroscience Rare Diseases	Phase 1/2	VIEW
106.	Bharat Biotech Hyderabad, India	Infectious Disease Oncology	Commercial	VIEW
107.	Bio Usawa Inc. San Mateo, USA / Kigali, Rwanda	Oncology Infectious Disease Ophthalmology	Preclinical	VIEW
108.	Bio-Gene Technology Limited Shatin, Hong Kong		-	VIEW
109.	BioCardia, Inc. Sunnyvale, California, USA	Cardiovascular Respiratory	Phase 3	VIEW
110.	BioData Solutions Lawrence, Kansas, USA	Oncology Rare Diseases	-	VIEW
111.	BioInvent International AB Lund, Sweden	Oncology	Phase 2	VIEW
112.	BioLineRx Ltd. Modiin, Israel	Oncology Rare Diseases	Commercial	VIEW
113.	BioMarin Pharmaceutical Inc. San Rafael, USA	Hematology Metabolic Cardiovascular	Commercial	VIEW
114.	BioMed Valley Discoveries Kansas City, Missouri, USA	Oncology Immunology Rare Diseases+1	Clinical (Phase 1-2)	VIEW
115.	BioNTech Mainz, Germany	Oncology Immunology Infectious Disease	Phase 1-3	VIEW
116.	BioNTech SE Mainz, Germany	Oncology Infectious Disease Rare Diseases	Commercial	VIEW
117.	BioPharma Network Milan, Italy		-	VIEW
118.	Biocase Brasil Itajaí, Brazil		Preclinical	VIEW
119.	Biohaven Ltd. New Haven, USA	Neuroscience Immunology Oncology+1	Phase 3	VIEW
120.	Biological E. Limited Hyderabad, India	Infectious Disease Gastroenterology	Commercial	VIEW
121.	Biomea Fusion San Carlos, USA	Metabolic Oncology	Phase 2	VIEW
122.	Bionexus (주식회사 바이오넥서스) Suwon, South Korea		Discovery	VIEW
123.	Bioreaction.tech (Bioreaction.tech Kft.) Debrecen, Hungary		Seed	VIEW
124.	Biotest AG Dreieich, Germany	Hematology	Phase 2\|Phase 3\|Commercial	VIEW
125.	Biotest AG Dreieich (Frankfurt), Germany	Hematology	Phase 3/Commercial	VIEW
126.	Biovet AD Peshtera, Bulgaria		Commercial	VIEW
127.	BlueRock Therapeutics Cambridge, USA	Neuroscience Cardiovascular Ophthalmology+1	Phase 3	VIEW
128.	Blueprint Medicines Cambridge, USA	Oncology Hematology Immunology+1	Commercial	VIEW
129.	Boostimmune Seoul, South Korea	Oncology Immunology	Preclinical	VIEW
130.	Bota Biosciences Hangzhou, China (International HQ in Lafayette, CA, USA)		Commercial	VIEW
131.	BridgeBio Oncology Therapeutics, Inc. South San Francisco, USA	Oncology	Phase 1	VIEW
132.	BunyaVax Lelystad, Netherlands	Infectious Disease Oncology	Phase 1	VIEW
133.	Burke Therapeutics, LLC Hot Springs, Arkansas, USA	Dermatology	Discovery	VIEW
134.	C-Ray Therapeutics Chengdu, China	Oncology	Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
135.	CAMP4 Therapeutics Cambridge, USA	Rare Diseases	Phase 1	VIEW
136.	CDR-Life Schlieren, Zurich, Switzerland	Oncology Immunology Ophthalmology	Phase 1	VIEW
137.	CECOS University of Information Technology and Emerging Sciences Peshawar, Pakistan	Oncology Neuroscience Infectious Disease	Preclinical	VIEW
138.	CEPI Oslo, Norway	Infectious Disease	Commercial	VIEW
139.	CF PharmTech, Inc. Suzhou, China	Respiratory	Commercial	VIEW
140.	CG Oncology, Inc. Irvine, USA	Oncology	Phase 3	VIEW
141.	CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland	Oncology Immunology Neuroscience+2	Phase 3	VIEW
142.	CS Pharmaceuticals Limited London, United Kingdom	Ophthalmology Rare Diseases	Phase 2	VIEW
143.	CSM Consulting, LLC United States	Cell Therapy Gene Therapy	-	VIEW
144.	CURE5 Foundation New York, USA	Rare Diseases Neuroscience	Discovery	VIEW
145.	Cabaletta Bio, Inc. Philadelphia, USA	Immunology Neuroscience Dermatology	Phase 1/2	VIEW
146.	Cal Crop USA USA		-	VIEW
147.	Caldera Therapeutics Cambridge, USA	Immunology Gastroenterology	Phase 1	VIEW
148.	Calico Life Sciences South San Francisco, United States	Oncology Neuroscience Immunology	Phase 2	VIEW
149.	Calidi Biotherapeutics San Diego, USA	Oncology	Phase 2	VIEW
150.	Calliditas Therapeutics Stockholm, Sweden	Rare Diseases	Commercial	VIEW
151.	Calluna Pharma Oslo, Norway	Immunology	Phase 2	VIEW
152.	Camurus AB Lund, Sweden	Neuroscience Rare Diseases Metabolic+1	Commercial	VIEW
153.	CanariaBio Inc. Seoul, South Korea	Oncology	Phase 3	VIEW
154.	Cancer Research UK London, United Kingdom	Oncology	Phase 2	VIEW
155.	Cantargia AB Lund, Sweden	Oncology Immunology	Phase 1 - Phase 2	VIEW
156.	Cardurion Pharmaceuticals Burlington, United States	Cardiovascular	Phase 2	VIEW
157.	Caritas Healthcare Private Limited Ahmedabad, India	Oncology	Commercial	VIEW
158.	Carrick Therapeutics Dublin, Ireland	Oncology	Phase 2	VIEW
159.	Carroll Bio-Consulting Boston, USA	Oncology Rare Diseases	Commercial	VIEW
160.	Cell-Tx Seoul, South Korea	Neuroscience Oncology Ophthalmology	Preclinical	VIEW
161.	Cellectis Paris, France	Oncology Immunology Rare Diseases	Phase 2	VIEW
162.	Celon Pharma Łomianki, Poland	Neuroscience Oncology Immunology+1	Phase 3	VIEW
163.	Celularity Inc Florham Park, New Jersey, USA	Oncology	Phase 1/2 and Phase 2	VIEW
164.	Centaur Laboratories Private Limited Mumbai, India		-	VIEW
165.	Center for Neuromusculoskeletal Restorative Medicine Limited Shatin, Hong Kong	Neuroscience Rare Diseases	Preclinical	VIEW
166.	Center of Molecular Immunology (CIM) Havana, Cuba	Oncology Immunology	Commercial	VIEW
167.	Centrexion Therapeutics Boston, Massachusetts, United States	Immunology	Phase 1-3	VIEW
168.	Cerevel Therapeutics Cambridge, Massachusetts, USA		Phase 1-3	VIEW
169.	Changchun GeneScience Pharmaceutical Co., Ltd. Changchun, China	Metabolic Oncology Immunology+1	Clinical	VIEW
170.	Chengdu Kanghong Pharmaceutical Group Chengdu, China	Ophthalmology Neuroscience Oncology	Commercial	VIEW
171.	Chiba University Chiba, Japan	Oncology Immunology Rare Diseases+3	Phase 2	VIEW
172.	China Medical System Holdings Ltd. Shenzhen, China	Dermatology Gastroenterology Ophthalmology+1	Commercial	VIEW
173.	China Medical University Hospital (CMUH) Taichung, Taiwan	Oncology Neuroscience Cardiovascular+2	Phase 2	VIEW
174.	Chongqing PegBio Biotechnology Co., Ltd. Chongqing, China	Gastroenterology Hematology Oncology	Phase 3	VIEW
175.	Choose Life Biotech SA Bellinzona, Switzerland	Immunology Infectious Disease Oncology	Preclinical	VIEW
176.	Chosun University Hospital Gwangju, South Korea	Oncology Metabolic Gastroenterology	Discovery	VIEW
177.	Chung-Ang University Seoul, South Korea	Oncology Cardiovascular Immunology+2	Phase 3	VIEW
178.	Cincinnati Children's Hospital Medical Center Cincinnati, USA	Oncology Immunology Rare Diseases+4	Commercial	VIEW
179.	Circio Holding ASA Lysaker, Norway	Oncology Immunology Gene Therapy	Phase 1/2	VIEW
180.	City of Hope Duarte, California, USA	Oncology Hematology Rare Diseases	Commercial	VIEW
181.	Clasp Therapeutics Rockville, Maryland, USA	Oncology	Phase 1	VIEW
182.	Clinny Bio		-	VIEW
183.	Clinuvel Pharmaceuticals Melbourne, Australia	Rare Diseases Dermatology Neuroscience	Commercial	VIEW
184.	Codexis, Inc. Redwood City, California, USA	Rare Diseases Metabolic	Commercial	VIEW
185.	Coherus BioSciences, Inc. Redwood City, USA	Oncology	Commercial	VIEW
186.	College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences (SRIPMS) Coimbatore, India		-	VIEW
187.	Comanche Biopharma Corp. Concord, USA		Phase 1	VIEW
188.	Complement Therapeutics United Kingdom (University of Manchester spinout, with facilities in UK and Germany)	Ophthalmology	Phase I/II	VIEW
189.	Constructor Group Schaffhausen, Switzerland	Oncology Infectious Disease Neuroscience	Preclinical	VIEW
190.	Corline Biomedical AB Uppsala, Sweden	Metabolic Cardiovascular Neuroscience	Phase 2	VIEW
191.	Corona Remedies Limited Ahmedabad, India	Cardiovascular Gastroenterology Respiratory	Commercial	VIEW
192.	Cosmo Pharmaceuticals N.V. Dublin, Ireland	Gastroenterology Dermatology Infectious Disease	Commercial	VIEW
193.	Coya Therapeutics, Inc. Houston, USA	Immunology	Phase 2	VIEW
194.	Createrna Science and Technology Wuhan, China	Cardiovascular Respiratory Immunology	Phase 2	VIEW
195.	Crescent Biopharma, Inc. Waltham, USA	Oncology	Phase 1/2	VIEW
196.	Crixmor LLC Malvern, Pennsylvania, USA	Immunology Gastroenterology Oncology	Discovery	VIEW
197.	CryoLife Scientific LLP Thane, India		Discovery	VIEW
198.	Cugene Inc. Waltham, USA	Oncology Immunology	Phase 1	VIEW
199.	Cullinan Therapeutics Cambridge, USA	Oncology Immunology	Phase 3	VIEW
200.	CuraTeQ Biologics Hyderabad, India	Oncology Immunology Metabolic	Commercial	VIEW
201.	CuraVac Rixensart, Belgium	Immunology	Phase 1B (completed) \| Phase 2 (in preparation)	VIEW
202.	Curadev Pharma Pvt Ltd Noida, India	Oncology Immunology Metabolic	Phase 1	VIEW
203.	Curaleaf Holdings, Inc. Wakefield, Massachusetts, USA		Commercial	VIEW
204.	Curasight Copenhagen, Denmark	Oncology	Phase 1-2 Clinical	VIEW
205.	Curatis Liestal, Switzerland	Oncology Neuroscience Respiratory+1	Phase 3	VIEW
206.	Curative Biotechnology Inc Boca Raton, Florida, USA	Infectious Disease	Pre-Clinical\|IND-Enabling Studies	VIEW
207.	CureVac Tübingen, Germany	Oncology Infectious Disease Rare Diseases	Phase 2	VIEW
208.	CytoAgents Pittsburgh, USA	Oncology Immunology Infectious Disease+1	Phase 2	VIEW
209.	CytoDyn Inc Vancouver, Washington	Oncology Immunology	Phase 2 clinical	VIEW
210.	CytoImmune Therapeutics Duarte, USA	Oncology Hematology Immunology	Phase 1	VIEW
211.	CytoSen Therapeutics Orlando (Winter Springs), Florida, USA	Oncology Cell Therapy Immunology	Phase 2	VIEW
212.	CytoTools AG Heidelberg, Germany	Dermatology Cardiovascular Oncology	Phase 3	VIEW
213.	CytoVac Hørsholm, Denmark	Oncology	Phase 2	VIEW
214.	Cytochroma Edinburgh, United Kingdom	Cardiovascular Rare Diseases	Discovery	VIEW
215.	Cytocom, Inc. Fort Collins, Colorado, USA	Oncology Infectious Disease Hematology+1	Phase 2/Phase 3	VIEW
216.	CytomX Therapeutics, Inc. South San Francisco, California, United States	Oncology	Phase 1 (clinical), Preclinical (discovery collaborations)	VIEW
217.	Cytonics Corporation Jupiter, Florida, USA	Immunology	Phase 2	VIEW
218.	Cytonus Therapeutics Carlsbad, California, United States	Oncology Immunology Infectious Disease+1	Phase 1	VIEW
219.	Cytorex Biosciences Weston, Florida, USA	Oncology Metabolic Infectious Disease	Preclinical	VIEW
220.	Cytovation Bergen, Norway	Oncology Rare Diseases	Phase I/II - Phase II	VIEW
221.	Cytovia Therapeutics Aventura, Florida, USA	Oncology Immunology	Phase 1/2	VIEW
222.	Cyxone Malmö, Sweden	Immunology Neuroscience	Phase 2	VIEW
223.	D&D Pharmatech Seongnam-si, South Korea		Phase 2	VIEW
224.	DBV Technologies Châtillon, France	Immunology	Phase 3	VIEW
225.	Dankook University Yongin and Cheonan, South Korea	Oncology Neuroscience Rare Diseases+1	Phase 2	VIEW
226.	Dartmouth College Hanover, USA	Oncology Immunology Neuroscience+2	Phase 3	VIEW
227.	Day One Biopharmaceuticals Brisbane, United States	Oncology Rare Diseases	Commercial	VIEW
228.	Debiopharm Lausanne, Switzerland	Oncology Rare Diseases	Phase 1, Phase 2, Phase 3	VIEW
229.	Dendreon Pharmaceuticals Seal Beach, USA	Oncology	Commercial	VIEW
230.	DevaCell, Inc. San Diego, USA	Oncology Infectious Disease Gene Therapy	Preclinical	VIEW
231.	Development Center for Biotechnology (DCB) Taipei, Taiwan	Oncology Immunology Infectious Disease	Preclinical	VIEW
232.	Dexa Medica Tangerang, Indonesia	Oncology	Commercial	VIEW
233.	Dexcel Pharma Or Akiva, Israel	Oncology Cardiovascular Neuroscience+2	Commercial	VIEW
234.	DifGen Pharmaceuticals Miramar, USA	Ophthalmology Neuroscience	Commercial	VIEW
235.	Differential Bio Munich, Germany		Commercial	VIEW
236.	Dizal Pharmaceutical Shanghai, China	Oncology Immunology	Commercial	VIEW
237.	Dolomite TX		-	VIEW
238.	Dolor Therapeutics, Inc. Chicago, USA	Immunology	Preclinical	VIEW
239.	Dompé Farmaceutici Milan, Italy	Ophthalmology Rare Diseases Metabolic+2	Commercial	VIEW
240.	Drugs for Neglected Diseases initiative (DNDi) Geneva, Switzerland	Infectious Disease	Commercial	VIEW
241.	Duality Biologics Shanghai, China	Oncology Immunology	Phase 3	VIEW
242.	Duopharma Biotech Berhad Kuala Lumpur, Malaysia	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
243.	Dyne Therapeutics, Inc. Waltham, Massachusetts, USA		Phase 1/2, Phase 3	VIEW
244.	E-Flask Seongnam, South Korea	Neuroscience Oncology	Phase 1	VIEW
245.	EEE Pharma Maharashtra, India	Infectious Disease Immunology Cardiovascular+1	Commercial	VIEW
246.	ETH Zürich Zurich, Switzerland	Oncology Immunology Neuroscience+4	Discovery	VIEW
247.	EUBREAST Esslingen, Germany	Oncology	Phase 3	VIEW
248.	Edge Therapeutics, Inc. Princeton, New Jersey, USA	Oncology Infectious Disease	Phase 3	VIEW
249.	Edgewise Therapeutics Boulder, USA		Phase 2	VIEW
250.	Efroze Chemical Industries (Pvt.) Ltd. Karachi, Pakistan	Cardiovascular Gastroenterology	Commercial	VIEW
251.	Eledon Pharmaceuticals Irvine, USA	Immunology	Phase 2	VIEW
252.	Elevar Therapeutics Fort Lee, USA	Oncology	Phase 3	VIEW
253.	Eleven Therapeutics Cambridge, United Kingdom	Infectious Disease	Discovery	VIEW
254.	Elixiron Immunotherapeutics Taipei, Taiwan	Oncology Immunology	Phase 2	VIEW
255.	Ellipses Pharma London, United Kingdom	Oncology	Phase 1/2	VIEW
256.	Emergent BioSolutions Gaithersburg, Maryland, USA	Infectious Disease	Commercial	VIEW
257.	Empresa de Laboratorios AICA La Lisa, Havana, Cuba	Infectious Disease Oncology	Commercial	VIEW
258.	Enanta Pharmaceuticals, Inc. Watertown, Massachusetts, USA	Immunology	Phase 1-2 clinical	VIEW
259.	Eneapharm Labège, France	Gastroenterology Rare Diseases	Clinical	VIEW
260.	Enlivex Therapeutics Ltd. Ness Ziona, Israel	Immunology Oncology Infectious Disease	Phase 2	VIEW
261.	Ensem Therapeutics Waltham, MA, USA	Oncology	Phase 1/2	VIEW
262.	Entact Bio Watertown, USA	Oncology Immunology Rare Diseases	Preclinical	VIEW
263.	Epione Medicine ApS Hvidovre, Denmark		-	VIEW
264.	Eris Therapeutics Limited Ahmedabad, India	Cardiovascular Gastroenterology Dermatology	Commercial	VIEW
265.	Estetra SRL Liège, Belgium	Oncology	Commercial	VIEW
266.	Eugia US LLC East Windsor, New Jersey, USA	Oncology Respiratory Hematology+2	Commercial	VIEW
267.	EurimPharm Arzneimittel GmbH Saaldorf-Surheim, Germany	Oncology Immunology Neuroscience+2	Commercial	VIEW
268.	Everest Medicines Shanghai, China	Immunology Oncology Cardiovascular+1	Commercial	VIEW
269.	Evopoint Biosciences Suzhou, China	Oncology Infectious Disease Immunology	Commercial (NDA Stage)	VIEW
270.	Evotec SE Hamburg, Germany	Oncology Neuroscience Infectious Disease+1	Commercial	VIEW
271.	Exelixis Alameda, USA	Oncology	Commercial	VIEW
272.	Exeltis Florham Park, USA (Global HQ in Madrid, Spain)	Neuroscience Respiratory Dermatology+2	Commercial	VIEW
273.	Exlixis		-	VIEW
274.	FDC Limited Mumbai, India	Gastroenterology Ophthalmology Cardiovascular+2	Commercial	VIEW
275.	FNCT Biotech Seongnam-si, South Korea	Oncology Immunology	Preclinical	VIEW
276.	Faes Farma Leioa, Spain	Gastroenterology Ophthalmology Dermatology	Phase 3	VIEW
277.	Fapon Dongguan, China	Oncology Immunology Infectious Disease	Preclinical	VIEW
278.	Fate Therapeutics, Inc. San Diego, USA	Oncology	Phase 1	VIEW
279.	Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil	Infectious Disease Vaccines Rare Diseases+1	Commercial	VIEW
280.	Fishfa Biogenics Rajkot, India	Immunology Infectious Disease Oncology+1	Commercial	VIEW
281.	Flagship Pioneering Cambridge, USA	Oncology Immunology Cardiovascular+2	Discovery	VIEW
282.	Flare Therapeutics Cambridge, MA, USA	Oncology	Phase 1-1B	VIEW
283.	FluGen, Inc. Madison, USA	Infectious Disease	Phase 2	VIEW
284.	Focus Care Pharmaceuticals B.V. Zaandam, Netherlands	Respiratory Neuroscience Cardiovascular+1	Commercial	VIEW
285.	Forma Therapeutics Inc Watertown, USA	Hematology Oncology Rare Diseases	Phase 3	VIEW
286.	Formation Bio New York, USA	Immunology Dermatology Neuroscience	Phase 3	VIEW
287.	Formycon AG Planegg-Martinsried, Germany	Ophthalmology Immunology	Commercial	VIEW
288.	Frontier Medicines South San Francisco, USA	Oncology Immunology	Phase 1/2	VIEW
289.	Fundação Butantan São Paulo, Brazil	Infectious Disease	Phase 2	VIEW
290.	Fusion Pharmaceuticals Inc. Hamilton, Ontario, Canada	Oncology	Phase 1\|Phase 2\|Phase 3	VIEW
291.	G. H. Raisoni University Saikheda, India	Oncology Metabolic Neuroscience+1	Discovery	VIEW
292.	GEN İlaç Ankara, Turkey	Oncology Neuroscience Metabolic+3	Phase 1\|Phase 2\|Commercial	VIEW
293.	GENFIT Loos, France	Metabolic	Phase 2	VIEW
294.	GNT Pharma Yongin, South Korea	Neuroscience Respiratory	Phase 3	VIEW
295.	Galapagos NV Mechelen, Belgium	Immunology Oncology	Phase 2	VIEW
296.	Galpha Laboratories Limited Mumbai, India	Infectious Disease Gastroenterology Dermatology	Commercial	VIEW
297.	Gan & Lee Pharmaceuticals Beijing, China	Metabolic Oncology Cardiovascular	Commercial	VIEW
298.	GenAns Biotech Beijing, China	Neuroscience Ophthalmology Oncology	Preclinical	VIEW
299.	GenLumina Leiden, Netherlands	Oncology	Preclinical	VIEW
300.	Gene Oasis Singapore, Singapore	Oncology Neuroscience Immunology+1	Clinical	VIEW
301.	GeneBiology, Inc. Research Triangle Park, North Carolina, USA	Oncology Neuroscience Gastroenterology	Clinical	VIEW
302.	GeneScience Pharmaceuticals Co., Ltd. (GenSci) Changchun, China	Metabolic Immunology Respiratory+1	Commercial	VIEW
303.	Genentech South San Francisco, California, United States	Oncology Immunology Rare Diseases+3	Discovery through Commercial	VIEW
304.	Genmab Copenhagen, Denmark	Oncology Hematology Immunology	Commercial	VIEW
305.	Gensciences Nantong, China	Hematology	Phase 3	VIEW
306.	George Mason University Fairfax, USA	Oncology Infectious Disease Metabolic+2	Phase 2	VIEW
307.	Georgia Southern University Statesboro, USA	Oncology Infectious Disease Neuroscience+1	Discovery	VIEW
308.	Gesynta Pharma AB Stockholm, Sweden		Phase 2	VIEW
309.	Ghosts Past		-	VIEW
310.	Google (Google DeepMind / Isomorphic Labs) London, United Kingdom	Oncology Immunology Cardiovascular	Preclinical	VIEW
311.	Granite Bio Basel, Switzerland	Immunology	Phase 1	VIEW
312.	Grupo Leti Guarenas, Venezuela	Cardiovascular Metabolic Gastroenterology+2	Commercial	VIEW
313.	Grupo Medifarma, S.A. de C.V. Jiutepec, Mexico	Gastroenterology	Commercial	VIEW
314.	Guangzhou Cellprotek Pharmaceutical Guangzhou, China	Neuroscience Cardiovascular Immunology+1	Phase 3 (Planning)	VIEW
315.	HBM Partners Zug, Switzerland	Oncology Immunology Neuroscience+3	Commercial	VIEW
316.	HCW Biologics Inc. Miramar, Florida, USA	Oncology Immunology	Phase 2	VIEW
317.	HERMES Arzneimittel Holding Pullach im Isartal, Germany		Commercial	VIEW
318.	HERVolution Therapeutics Copenhagen, Denmark	Oncology	Preclinical	VIEW
319.	HGFH (Placeholder Entity) N/A		Discovery	VIEW
320.	HIPRA Amer, Spain		Commercial	VIEW
321.	HLB PEP Co., Ltd. Gwangju, South Korea	Oncology Rare Diseases Immunology	Preclinical	VIEW
322.	HUN-REN Veterinary Medical Research Institute (VMRI) Budapest, Hungary	Infectious Disease	Discovery	VIEW
323.	HUTCHMED Hong Kong	Oncology Immunology Dermatology	Discovery to Phase III	VIEW
324.	Halo Life Science Austin, Texas, United States	Immunology	Discovery	VIEW
325.	Halozyme Therapeutics San Diego, USA	Oncology Immunology Neuroscience+3	Commercial	VIEW
326.	Hamad Bin Khalifa University (HBKU) Doha, Qatar	Oncology Metabolic Infectious Disease+1	Preclinical	VIEW
327.	Hanmi Pharmaceutical Co., Ltd. Seoul, South Korea	Oncology Metabolic Rare Diseases+1	Commercial	VIEW
328.	Hansa Biopharma Lund, Sweden	Immunology Gene Therapy Oncology	Commercial	VIEW
329.	Hansoh Pharmaceutical Group Co., Ltd. Shanghai, China	Oncology Neuroscience Metabolic+1	Phase 3	VIEW
330.	Hanyang University Seoul, South Korea	Oncology Neuroscience Infectious Disease+1	Phase 2	VIEW
331.	Harbour BioMed Shanghai, China	Oncology Immunology Ophthalmology	Phase 3	VIEW
332.	Harmony Biosciences Holdings, Inc. Plymouth Meeting, USA	Neuroscience Rare Diseases	Commercial	VIEW
333.	Healios K.K. Tokyo, Japan	Neuroscience Oncology Ophthalmology	Phase 3	VIEW
334.	Healis Therapeutics Cambridge, USA	Neuroscience	Phase 2/3	VIEW
335.	Health Hope Pharma Hong Kong, Hong Kong	Oncology	Phase 3	VIEW
336.	Heligenics Phoenix, Arizona, USA	Oncology Rare Diseases	Discovery	VIEW
337.	Hemerion Therapeutics Villeneuve d'Ascq, France	Oncology	Phase 1/2	VIEW
338.	Heranova Lifesciences Burlington, MA, USA		Clinical	VIEW
339.	Hetero Drugs Limited Hyderabad, India	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
340.	Hevolution Foundation Riyadh, Saudi Arabia	Oncology Neuroscience Rare Diseases	Discovery	VIEW
341.	Highnoon Laboratories Limited Lahore, Pakistan	Cardiovascular Gastroenterology Metabolic+2	Commercial	VIEW
342.	Himont Group Lahore, Pakistan		Commercial	VIEW
343.	Holostem S.r.l. Modena, Italy	Ophthalmology Dermatology Rare Diseases	Commercial	VIEW
344.	Hone Bio Bristol, United Kingdom	Oncology Cardiovascular	Preclinical	VIEW
345.	Hong Kong University of Science and Technology (Guangzhou) Guangzhou, China	Oncology Neuroscience Ophthalmology+1	Phase 2	VIEW
346.	Howard University Washington, D.C., USA	Oncology Immunology Cardiovascular	Discovery	VIEW
347.	Huahui Health Ltd. Beijing, China	Oncology	Commercial	VIEW
348.	Hudson Pharmaceuticals Ltd. Dhaka, Bangladesh	Respiratory Ophthalmology Gastroenterology+2	Commercial	VIEW
349.	Humanitas Research Hospital (IRCCS) Rozzano (Milan), Italy	Oncology Immunology Cardiovascular+1	Discovery	VIEW
350.	Humanova Lab Corporation Coral Gables, USA (Registered); Lima, Peru (Operational)		Commercial	VIEW
351.	Humatrix Medical Suzhou, China	Cardiovascular	Preclinical/Early Clinical	VIEW
352.	Huons Co., Ltd. Seongnam, South Korea	Ophthalmology Metabolic	Commercial	VIEW
353.	Hyloris Pharmaceuticals SA Liège, Belgium	Cardiovascular Infectious Disease Oncology+1	Commercial	VIEW
354.	Hyphens Pharma Singapore, Singapore	Dermatology	Commercial	VIEW
355.	IBSA Institut Biochimique SA Lugano, Switzerland	Metabolic Dermatology Respiratory	Commercial	VIEW
356.	IMIDomics, Inc. San Rafael, USA	Immunology Dermatology	Discovery	VIEW
357.	IMTR Inc. Tokyo, Japan	Immunology Hematology Gastroenterology	Phase 1/2	VIEW
358.	IPS Biopharma AG Bern, Switzerland	Oncology Infectious Disease	Phase 2	VIEW
359.	ITESO, Universidad Jesuita de Guadalajara Tlaquepaque, Mexico		Discovery	VIEW
360.	Iasis Pharma Kamatero, Greece	Cardiovascular Dermatology Gastroenterology+3	Commercial	VIEW
361.	Ibn Al-Haytham Pharmaceutical Industries Aleppo, Syria	Cardiovascular	Commercial	VIEW
362.	Idorsia Allschwil, Switzerland	Neuroscience Cardiovascular Immunology+1	Commercial	VIEW
363.	Imexpharm Corporation Cao Lãnh, Vietnam	Cardiovascular Gastroenterology Metabolic+2	Commercial	VIEW
364.	Immorna Biotherapeutics Morrisville, USA	Oncology Infectious Disease Dermatology+1	Phase 2	VIEW
365.	Immune System Key Ltd. (ISK) Jerusalem, Israel	Oncology	Phase 2	VIEW
366.	Immuneel Therapeutics Bengaluru, India	Oncology Hematology Immunology	Commercial	VIEW
367.	Immunethep Cantanhede, Portugal	Infectious Disease Immunology	Preclinical	VIEW
368.	Immunis, Inc. Irvine, California, USA	Immunology	Phase 1/2	VIEW
369.	Immunocore Abingdon, United Kingdom	Oncology Infectious Disease Immunology	Commercial	VIEW
370.	Immunome, Inc. Bothell, Washington, USA	Oncology	Phase 3	VIEW
371.	Immunomic Therapeutics, Inc. Rockville, Maryland, United States	Oncology Infectious Disease	Phase 1 - Phase 2	VIEW
372.	Immunophotonics Saint Louis, Missouri, USA	Oncology Immunology	Phase 2/3	VIEW
373.	Immunovant, Inc. Durham, North Carolina, USA	Immunology Neuroscience Metabolic+1	Phase 3	VIEW
374.	Incepta Vaccine Ltd. Dhaka, Bangladesh	Infectious Disease	Commercial	VIEW
375.	Incyte Wilmington, Delaware, USA	Oncology Hematology Dermatology+1	Commercial	VIEW
376.	Indian Immunologicals Limited Hyderabad, India	Infectious Disease Immunology	Commercial	VIEW
377.	Indoco Remedies Limited Mumbai, India	Respiratory Cardiovascular	Commercial	VIEW
378.	Industrial Technology Research Institute (ITRI) Hsinchu County, Taiwan		Discovery	VIEW
379.	Infinitopes Oxford, United Kingdom	Oncology	Phase 1/IIa	VIEW
380.	Ingpharm (ООО ИНЖФАРМ) Moscow, Russia		-	VIEW
381.	Initial Therapeutics South San Francisco, USA	Oncology Rare Diseases	Discovery	VIEW
382.	Innovacell Tokyo, Japan	Gastroenterology	Phase 3	VIEW
383.	Innovative Cell Technologies, Inc. San Diego, United States		Commercial	VIEW
384.	Innovent Biologics, Inc. Suzhou, China	Oncology	Commercial	VIEW
385.	Inresa Arzneimittel GmbH Freiburg im Breisgau, Germany	Oncology Infectious Disease	Commercial	VIEW
386.	InsilicoX Co., Ltd. Seoul, South Korea		Discovery	VIEW
387.	Insmed Incorporated Bridgewater, New Jersey, USA	Immunology Rare Diseases	Commercial	VIEW
388.	Institute for Bioengineering of Catalonia (IBEC) Barcelona, Spain	Oncology Neuroscience Rare Diseases+2	Preclinical	VIEW
389.	Institute of Immunology (Imunološki zavod) Zagreb, Croatia	Infectious Disease Immunology	Discovery	VIEW
390.	Instituto Politécnico Nacional (IPN) Mexico City, Mexico	Oncology Rare Diseases Infectious Disease	Discovery	VIEW
391.	Insud Pharma Madrid, Spain	Neuroscience Oncology Cardiovascular+3	Commercial	VIEW
392.	Intas Pharmaceuticals Limited Ahmedabad, India	Oncology Immunology Cardiovascular+2	Commercial	VIEW
393.	Intellia Therapeutics Cambridge, USA	Rare Diseases Cardiovascular Neuroscience+2	Phase 3	VIEW
394.	Intelligene Taipei, Taiwan	Infectious Disease	Phase 1	VIEW
395.	International Centre of Insect Physiology and Ecology (ICIPE) Nairobi, Kenya	Infectious Disease	Discovery\|Preclinical\|Phase 2	VIEW
396.	International Livestock Research Institute (ILRI) Nairobi, Kenya	Infectious Disease	Commercial	VIEW
397.	Interventional AnalgesiX Inc. Durham, North Carolina, United States		Preclinical	VIEW
398.	Intrommune Therapeutics New York, USA	Immunology	Phase 1	VIEW
399.	Inventiva Pharma Daix, France	Oncology	Phase 3	VIEW
400.	Ionis Pharmaceuticals, Inc. Carlsbad, California, United States	Neuroscience Cardiovascular Immunology+1	Phase 1 through Commercial	VIEW
401.	Ionis Pharmaceuticals, Inc. Carlsbad, USA	Neuroscience Rare Diseases	Commercial	VIEW
402.	Ironwood Pharmaceuticals Boston, USA	Gastroenterology Rare Diseases	Commercial	VIEW
403.	J-Pharma Co., Ltd. Tokyo, Japan	Oncology Neuroscience Immunology	Phase 3	VIEW
404.	JCR Pharmaceuticals Co., Ltd. Ashiya, Japan	Rare Diseases Neuroscience	Phase 3	VIEW
405.	Janux Therapeutics San Diego, California, USA	Oncology Immunology	Phase 1	VIEW
406.	Japan Institute for Health Security Shinjuku-ku, Tokyo, Japan	Infectious Disease Vaccines	Discovery	VIEW
407.	Jeil Pharmaceutical Co., Ltd. Seoul, South Korea	Oncology Cardiovascular Gastroenterology+2	Phase 2	VIEW
408.	Jiangsu Hengrui Medicine Co., Ltd. Lianyungang, China	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
409.	Jiayue Pharmaceutical Guangzhou, China	Oncology Immunology Infectious Disease	Phase 3	VIEW
410.	Jubilant Therapeutics Bedminster, NJ, United States	Oncology Immunology	Phase I/II Clinical	VIEW
411.	Julphar (Gulf Pharmaceutical Industries) Ras Al Khaimah, United Arab Emirates	Metabolic Gastroenterology Respiratory+4	Commercial	VIEW
412.	Jumpcan Pharmaceutical Taixing, Jiangsu, China	Gastroenterology Respiratory Oncology+1	Commercial	VIEW
413.	Junshi Biosciences Shanghai, China	Oncology Immunology Metabolic+1	Commercial	VIEW
414.	KM Biologics Co., Ltd. Kumamoto, Japan	Infectious Disease Hematology Immunology	Commercial	VIEW
415.	Kailera Therapeutics Waltham, MA, USA	Metabolic	Phase 3	VIEW
416.	KaliVir Immunotherapeutics Pittsburgh, Pennsylvania, USA	Oncology Immunology	Phase 1/1b Clinical	VIEW
417.	Kaohsiung Medical University Kaohsiung, Taiwan	Oncology Infectious Disease	Discovery	VIEW
418.	Kardigan South San Francisco, USA		Phase 2/3	VIEW
419.	Karolinska Institutet Stockholm, Sweden	Oncology Immunology Cardiovascular+1	Discovery	VIEW
420.	Karyon Bio Bengaluru, India (with US presence in Mountain View, California)		Discovery	VIEW
421.	Kedrion Biopharma Barga, Italy	Immunology Hematology Rare Diseases	Commercial	VIEW
422.	Kenai Therapeutics San Diego, USA	Neuroscience	Phase 1	VIEW
423.	Keros Therapeutics Lexington, Massachusetts, United States	Hematology Respiratory Cardiovascular	Phase 1-3	VIEW
424.	Khartis Therapeutics, Inc. San Diego, USA	Immunology	Discovery	VIEW
425.	King Faisal Specialist Hospital and Research Centre (KFSHRC) Riyadh, Saudi Arabia	Oncology Cardiovascular Neuroscience	Clinical	VIEW
426.	Kiniksa Pharmaceuticals London, United Kingdom	Cardiovascular Immunology Rare Diseases	Commercial	VIEW
427.	Kitasato University Tokyo, Japan	Oncology Immunology Neuroscience+1	Discovery	VIEW
428.	Knight Therapeutics Inc. Montreal, Canada	Oncology Hematology Infectious Disease+2	Commercial	VIEW
429.	Kobayashi Pharmaceutical Co., Ltd. Osaka, Japan	Gastroenterology Dermatology	Commercial	VIEW
430.	Korea Regulatory Science Center Seoul, South Korea		-	VIEW
431.	KromaTiD, Inc. Longmont, USA	Oncology Rare Diseases Gene Therapy+1	Discovery	VIEW
432.	Krystal Biotech, Inc. Pittsburgh, USA	Dermatology Respiratory Oncology+1	Commercial	VIEW
433.	Kura Oncology Inc San Diego, California, USA	Oncology	Phase 1\|Phase 2\|Phase 3\|Approved	VIEW
434.	Kymera Therapeutics, Inc. Watertown, Massachusetts, USA	Immunology Oncology	Phase 2	VIEW
435.	Kyung Hee University Seoul, South Korea	Oncology Neuroscience Immunology+1	Phase 3	VIEW
436.	LFB USA Framingham, USA	Immunology	Commercial	VIEW
437.	LG Business Research Seoul, South Korea	Oncology Immunology Vaccines	Commercial	VIEW
438.	Laboratoire Aguettant Lyon, France	Neuroscience	Commercial	VIEW
439.	Laboratorios Bagó Buenos Aires, Argentina	Oncology Hematology Cardiovascular+3	Commercial	VIEW
440.	Laboratorios Liomont, S.A. de C.V. Ciudad de México, Mexico	Oncology Immunology Infectious Disease+1	Commercial	VIEW
441.	Laboratorios Pharmor SAS Funza, Colombia		Discovery	VIEW
442.	Laboratorios Silanes Mexico City, Mexico	Metabolic Cardiovascular Respiratory+1	Commercial	VIEW
443.	Laboratorios Vita S.A. La Paz, Bolivia	Respiratory	Commercial	VIEW
444.	Laboratorios Viñas Barcelona, Spain	Dermatology	Commercial	VIEW
445.	Ladophar (Lam Dong Pharmaceutical Joint Stock Company) Da Lat, Vietnam		Commercial	VIEW
446.	Lamark Biotech Ahmedabad, India	Oncology	Preclinical	VIEW
447.	Lamyra London, United Kingdom	Dermatology Gastroenterology	Commercial	VIEW
448.	Lantheus Holdings, Inc. Bedford, Massachusetts, USA	Oncology Neuroscience Cardiovascular	Commercial	VIEW
449.	Laurent Pharmaceuticals Montreal, Quebec, Canada		Phase 2/3	VIEW
450.	Legend Biotech Somerset, USA	Oncology Infectious Disease	Commercial	VIEW
451.	Lepu Biopharma Co., Ltd. Shanghai, China	Oncology	Commercial	VIEW
452.	LiBo Pharma Corp. New Taipei City, Taiwan	Oncology Hematology Immunology	Phase 2/Phase 3	VIEW
453.	Libio Technology Suzhou, China	Cardiovascular Metabolic	Phase 1	VIEW
454.	Lotus Pharmaceutical Co., Ltd. Taipei, Taiwan	Oncology Neuroscience Cardiovascular	Commercial	VIEW
455.	Luminar Life Sciences Lahore, Pakistan		Commercial	VIEW
456.	Luxembourg Institute of Health Strassen, Luxembourg	Oncology Immunology Infectious Disease	Discovery	VIEW
457.	MAB Discovery GmbH Polling, Germany	Oncology Immunology	Preclinical	VIEW
458.	MEPSGEN Seoul, South Korea	Neuroscience Oncology Rare Diseases	Preclinical	VIEW
459.	MS Pharma Amman, Jordan	Cardiovascular Neuroscience Respiratory+1	Commercial	VIEW
460.	MTI Medical (Pvt.) Ltd. Lahore, Pakistan	Metabolic Immunology Oncology+1	Commercial	VIEW
461.	Mahzi Therapeutics South San Francisco, USA	Rare Diseases	Phase 1/2	VIEW
462.	Malaysian Pharmaceutical Industries Sdn. Bhd. Bayan Lepas, Malaysia	Neuroscience Dermatology	Commercial	VIEW
463.	Mariana Oncology (via Carroll Bio Advisory) Watertown, Massachusetts	Oncology	Phase 1	VIEW
464.	Medac GmbH Wedel, Germany	Oncology Hematology Immunology	Commercial/Phase 3	VIEW
465.	Medical University of Vienna (Medizinische Universität Wien) Vienna, Austria	Oncology Immunology Metabolic+1	Discovery	VIEW
466.	MedinCell Montpellier, France		Commercial\|Phase 3\|Preclinical	VIEW
467.	Medison Pharma Petah Tikva, Israel	Oncology Rare Diseases Immunology+2	Commercial	VIEW
468.	Medley Pharmaceuticals Mumbai, India	Cardiovascular Gastroenterology	Commercial	VIEW
469.	Megalabs Canelones, Uruguay	Oncology Gastroenterology Cardiovascular	Development	VIEW
470.	Meitheal Pharmaceuticals Chicago, Illinois, United States	Oncology Metabolic	Phase 1-3 and Commercial	VIEW
471.	Menarini Stemline New York, USA	Oncology Hematology Rare Diseases	Commercial	VIEW
472.	Mersana Therapeutics Cambridge, USA	Oncology Rare Diseases	Phase 1	VIEW
473.	Merus N.V. Utrecht, Netherlands	Oncology	Commercial (BLA Stage)	VIEW
474.	Merz Pharma GmbH & Co. KGaA Frankfurt am Main, Germany	Neuroscience Dermatology	Phase 3	VIEW
475.	Mesa Green Pharma Frederick, USA	Neuroscience	Preclinical	VIEW
476.	Metagenomi Emeryville, USA	Hematology Cardiovascular Rare Diseases+1	Preclinical	VIEW
477.	Micro CRISPR Vapi, India	Oncology Hematology Metabolic+1	Preclinical	VIEW
478.	Micropep Technologies Auzeville-Tolosane, France		Preclinical	VIEW
479.	Millicent Pharma Dundalk, Ireland		Commercial	VIEW
480.	Miltenyi Biotec Bergisch Gladbach, Germany	Oncology Immunology Hematology	Commercial	VIEW
481.	Minovia Therapeutics Tirat Carmel, Israel	Rare Diseases Hematology	Phase 2	VIEW
482.	MiraxBioPharma (MB Pharma) Khimki, Russia	Oncology Neuroscience Dermatology+1	Commercial	VIEW
483.	Mirum Pharmaceuticals Foster City, USA	Rare Diseases	Commercial	VIEW
484.	Moderna Cambridge, USA	Infectious Disease Oncology Rare Diseases+2	Commercial	VIEW
485.	Mogam Institute for Biomedical Research Seoul, South Korea	Rare Diseases Infectious Disease Oncology+1	Discovery\|Preclinical	VIEW
486.	Monimoi Therapeutics Boston, USA	Oncology	Discovery	VIEW
487.	Mucpharm Kogarah, Sydney, New South Wales 2217, Australia	Oncology Rare Diseases	Phase 2	VIEW
488.	MultiOmic Health London, United Kingdom	Metabolic	Discovery	VIEW
489.	Muna Therapeutics Frederiksberg, Denmark		Phase 1	VIEW
490.	Myrio Therapeutics Melbourne, Australia	Oncology	Discovery	VIEW
491.	N4 Pharma Chellaston, Derbyshire, United Kingdom	Oncology	Preclinical	VIEW
492.	NBE Therapeutics Basel, Switzerland	Oncology	Phase 1/2	VIEW
493.	NEOM Tabuk, Saudi Arabia		Commercial	VIEW
494.	NKure Therapeutics Bengaluru, India	Oncology Infectious Disease	Preclinical	VIEW
495.	NMD Pharma A/S Aarhus, Denmark		Phase 2	VIEW
496.	NMDP Minneapolis, USA	Hematology Oncology Rare Diseases+1	Commercial	VIEW
497.	Nalu Bio San Francisco, USA		Preclinical	VIEW
498.	Nanocan Therapeutics Corporation Princeton, New Jersey (also noted as National Harbor, MD)	Oncology	Phase I/II	VIEW
499.	Nanogen Pharmaceutical Biotechnology JSC Ho Chi Minh City, Vietnam	Oncology Infectious Disease	Commercial	VIEW
500.	Nanophoria Milan, Italy	Cardiovascular Rare Diseases	Preclinical	VIEW